Zomedica Corp（ZOM）股票分析

$0.097

-0.000 (-0.21%)收盘时

Loading chart…

High: 0.097
Open: 0.092
VWAP: 0.10
Vol: 790.94K
Mkt Cap: 149.83M
Low: 0.092
Amount: 75.57K
EV/EBITDA, TTM: 0.00

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF).

估值指标

The current forward P/E ratio for Zomedica Corp (ZOM) is -3.25, compared to its 5-year average forward P/E of -3.15.

Forward P/E

Fair

5Y Average P/E

-3.15

Current P/E

-3.25

高估

11.78

低估

-18.08

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

高估

0.00

低估

0.00

Forward P/S

Fair

5Y Average P/S

18.49

Current P/S

3.02

高估

47.75

低估

-10.77

事件时间线

2026-03-18 (ET)

06:30:00

Zomedica Collaborates with Boehringer Ingelheim to Enhance Equine Endocrine Testing

2025-12-30 (ET)

06:40:00

Zomedica Launches VETGuardian PLUS Monitor

2025-07-10 (ET)

06:33:09

Zomedica enters PulseVet sponsorship agreement with WEC - Ocala

2024-10-03 (ET)

06:43:11

Zomedica announces expansion of equine distribution agreement with Grovet

06:34:47

Zomedica expands exclusive equine distribution pact with Grovet in Europe

Show More Events

资讯

ZOM FAQ — answered by Alphio AI

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF). It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).

本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。